• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number AFAPRO28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Chest Pain (1776); Dyspnea (1816); Muscle Weakness (1967); Myocardial Infarction (1969); Pneumonia (2011); Test Result (2695)
Event Date 05/27/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that after a cryo ablation procedure, the patient experienced dyspnea and angina pectoris.Blood tests and an echocardiogram were completed with abnormal results.The patient's hospital stay was extended; they were admitted with signs of pneumonia.Heart failure, cardiac decompensation and pneumonia occurred at the hospital.The patient had a recurrence of atrial tachycardia that was treated with cardioversion.The outcome of this case is unknown.The patient is a participant in the (b)(6) clinical study.No further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional incoming information indicates this patient did not have a recurrence of atrial tachycardia nor cardioversion.Additionally, the heart failure, cardiac decompensation and pneumonia were reported to not have occurred.Also, the site confirmed the initial case was completed with cryo.
 
Event Description
Additional information was received.It was reported that the patient's primary diagnosis was nstemi (non-st-elevation myocardial infarction).Blood tests were performed, and the patient's troponin was elevated.An echocardiogram performed at a later date showed the patient experienced abnormal apical akinesia.A chest x-ray and coronary angiography were performed, and were noted to be normal.The patient was treated with medication.The patient was diagnosed with a tako-tsubo cardiomyopathy.It was noted the adverse event resolved and is not related to the manufacturer products or procedure.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER
Type of Device
PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
MEDTRONIC CRYOCATH LP
9000 autoroute transcanadienne
pointe-claire,qc H9R 5 Z8
CA  H9R 5Z8
MDR Report Key8732885
MDR Text Key149136272
Report Number3002648230-2019-00460
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
PMA/PMN Number
P100010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/07/2021
Device Model NumberAFAPRO28
Device Catalogue NumberAFAPRO28
Device Lot Number04682
Was Device Available for Evaluation? No
Date Manufacturer Received09/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
Patient Weight93
-
-